These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9034241

  • 1. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate.
    Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC.
    Free Radic Biol Med; 1997; 22(6):1019-27. PubMed ID: 9034241
    [Abstract] [Full Text] [Related]

  • 2. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.
    Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER.
    Proc Natl Acad Sci U S A; 1994 Mar 29; 91(7):2616-20. PubMed ID: 8146163
    [Abstract] [Full Text] [Related]

  • 3. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney.
    Uchida K, Fukuda A, Kawakishi S, Hiai H, Toyokuni S.
    Arch Biochem Biophys; 1995 Mar 10; 317(2):405-11. PubMed ID: 7893156
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis.
    Iqbal M, Giri U, Giri DK, Alam MS, Athar M.
    Arch Biochem Biophys; 1999 May 01; 365(1):101-12. PubMed ID: 10222044
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats.
    Deguchi J, Miyamoto M, Okada S.
    Jpn J Cancer Res; 1995 Nov 01; 86(11):1068-71. PubMed ID: 8567398
    [Abstract] [Full Text] [Related]

  • 8. Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.
    Umemura T, Hasegawa R, Sai-Kato K, Nishikawa A, Furukawa F, Toyokuni S, Uchida K, Inoue T, Kurokawa Y.
    Jpn J Cancer Res; 1996 Sep 01; 87(9):882-6. PubMed ID: 8878448
    [Abstract] [Full Text] [Related]

  • 9. Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by Brazilian propolis and artepillin C.
    Kimoto T, Koya S, Hino K, Yamamoto Y, Nomura Y, Micallef MJ, Hanaya T, Arai S, Ikeda M, Kurimoto M.
    Pathol Int; 2000 Sep 01; 50(9):679-89. PubMed ID: 11012980
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate.
    Nishiyama Y, Tanaka T, Naitoh H, Mori C, Fukumoto M, Hiai H, Toyokuni S.
    Jpn J Cancer Res; 1997 Feb 01; 88(2):120-8. PubMed ID: 9119739
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin.
    Toyokuni S, Mori T, Hiai H, Dizdaroglu M.
    Int J Cancer; 1995 Jul 28; 62(3):309-13. PubMed ID: 7628872
    [Abstract] [Full Text] [Related]

  • 12. Localization of 4-hydroxy-2-nonenal-modified proteins in kidney following iron overload.
    Zainal TA, Weindruch R, Szweda LI, Oberley TD.
    Free Radic Biol Med; 1999 May 28; 26(9-10):1181-93. PubMed ID: 10381189
    [Abstract] [Full Text] [Related]

  • 13. Over-expression of glutathione S-transferase Yp isozyme and concomitant down-regulation of Ya isozyme in renal cell carcinoma of rats induced by ferric nitrilotriacetate.
    Tanaka T, Nishiyama Y, Okada K, Satoh K, Fukuda A, Uchida K, Osawa T, Hiai H, Toyokuni S.
    Carcinogenesis; 1998 May 28; 19(5):897-903. PubMed ID: 9635880
    [Abstract] [Full Text] [Related]

  • 14. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate.
    Toyokuni S, Mori T, Dizdaroglu M.
    Int J Cancer; 1994 Apr 01; 57(1):123-8. PubMed ID: 8150530
    [Abstract] [Full Text] [Related]

  • 15. Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA).
    Randerath E, Watson WP, Zhou GD, Chang J, Randerath K.
    Mutat Res; 1995 Feb 01; 341(4):265-79. PubMed ID: 7531286
    [Abstract] [Full Text] [Related]

  • 16. The therapeutic potential of curcumin in alleviating N-diethylnitrosamine and iron nitrilotriacetate induced renal cell tumours in mice via inhibition of oxidative stress: Implications for cancer chemoprevention.
    Iqbal M, Shah MD, Vun-Sang S, Okazaki Y, Okada S.
    Biomed Pharmacother; 2021 Jul 01; 139():111636. PubMed ID: 33957566
    [Abstract] [Full Text] [Related]

  • 17. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress.
    Athar M, Iqbal M.
    Carcinogenesis; 1998 Jun 01; 19(6):1133-9. PubMed ID: 9667754
    [Abstract] [Full Text] [Related]

  • 18. Lipid peroxidation in plasma of rats treated with ferric-nitrilotriacetate, in relation to kidney and liver modifications.
    Deiana M, Rosa A, Corona G, Collu S, Ennas MG, Dessì MA.
    Biofactors; 2005 Jun 01; 23(1):35-44. PubMed ID: 15817997
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme.
    Fukuda A, Osawa T, Oda H, Toyokuni S, Satoh K, Uchida K.
    Arch Biochem Biophys; 1996 May 01; 329(1):39-46. PubMed ID: 8619633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.